Johnson & Johnson Partners With U.S. Government On COVID-19 Vaccine Development

Johnson & Johnson announced that it had arranged a partnership with an arm of the U.S. Department of Health and Human Services to continue development on a vaccine to prevent COVID-19. Janssen Pharmaceutical Companies, a division of Johnson & Johnson, will work with the Biomedical Advanced Research and Development Authority (BARDA) to fund and quickly test their leading candidate for a coronavirus vaccine.

According to Johnson & Johnson, researchers began development of possible vaccines in January, after coronavirus’s genetic sequencing became available to researchers. Janssen’s research was conducted in collaboration with Beth Israel Deaconess Medical at . . .